Navigation Links
Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
Date:7/14/2009

g these, approximately 2,300 children and adolescents die of cancer each year making cancer the most common cause of disease-related mortality for children 1 to 19 years of age. (NCI SEER Data) There are 12 major types of childhood cancers, and of these leukemias, brain and other central nervous system tumors (ie, gliomas and medulloblastomas) account for over 50% of the new cases. The remainder of new cases include extracranial tumors such as neuroblastomas, Wilms tumors, and rhabdomyosarcomas. Although improvements in imaging equipment and treatments have resulted in an overall decline in mortality and increased survival, approximately half of all children with malignant solid tumors will experience relapse and, of these children, less than 10% will achieve long-term survival after standard multimodal therapy.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM)(ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also actively engages in
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 The Parenteral Drug ... has finalized agreement with Richard M. Johnson ... "We are very pleased to have Richard ... Hal Baseman , the Chair of the Board ... performance and growth.  Richard has led a strong staff ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Global Suture Industry Report 2015" ... Global Suture Industry Report 2015 is a professional ... the suture industry. The report provides ... classifications, applications and industry chain structure. The suture ...
(Date:5/6/2015)... South Africa , May 6, 2015 /PRNewswire/ ... people than HIV/AIDS, malaria and tuberculosis combined[1]. Approximately 40 percent ... be cured with the right treatment[3]. Together with Elekta, ministries ... to build up their radiation therapy infrastructures and save lives. ... worldwide would benefit from radiation therapy[4] during the course of ...
Breaking Medicine Technology:PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4
... 9, 2012  Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... diseases associated with inflammation, will release its fourth quarter ... February 21, 2012. Anthera will host a conference call ... release. The Company will also provide an update for ...
... Texas, Feb. 9, 2012   SmallCapVoice.com, Inc. announced ... PositiveID Corporation (OTCBB: PSID.OB), a developer of ... available. The interview can be heard at ... a recognized corporate investor relations firm, with ...
Cached Medicine Technology:Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call 2A New Audio Interview with PositiveID Chairman and CEO, William J. Caragol, is now at SmallCapVoice.com 2
(Date:5/6/2015)... Dallas, TX (PRWEB) May 06, 2015 ... 2, Issue 1 of Patient Experience Journal (PXJ), ... and proven practices around understanding and improving patient experience. ... elevating the patient experience conversation globally, helps align the ... and impact. , Published in association with The ...
(Date:5/6/2015)... Marketing Maven announces a ... sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. , “WaterAid ... and it brings our agency great joy to work ... “The ongoing relationship between WaterAid and Marketing ... learn about and support the nonprofit as they aim ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Wolters ... healthcare professionals and students, announced today that in a ... confirmed that use of the clinical decision support resource ... the end of 2014, UpToDate users in more than ... topics per month, on average. In Germany alone, 95% ...
(Date:5/6/2015)... 06, 2015 TU-Automotive has opened press ... autonomous vehicles make it to the headlines of major ... Nissan, GM, Volvo and Hyundai ready to share their ... is the only way for press to go behind ... Wright, marketing director, TU-Automotive said “This year we’re releasing ...
(Date:5/6/2015)... GA (PRWEB) May 06, 2015 ... chosen Hexagon Geospatial technology to manage and distribute imagery, ... Australia is one of the driest continents on earth, ... through times of drought and erratic seasonal rainfalls has ... supply solutions. , Water NSW manages raw water supplies ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3
... Sept. 4 The American Water Works,Association (AWWA) ... y,Saneamiento de Mexico, A.C. (ANEAS) -- the National ... established that they will share expertise,and resources through ... Ruiz Morcillo and Director Roberto Olivares met,with AWWA ...
... Study finds a 37% reduction in total sleep when moms ... Nicotine in breast milk disrupts babies, sleep patterns and shortens ... , "Infants spent less time sleeping overall and woke up ... lead author Julie A. Mennella, a psychobiologist at the Monell ...
... (Nasdaq and SWX: BMRN) announced today that Emil,Kakkis, M.D., ... update at the Bear Stearns 20th Annual Healthcare Conference ... 3:00 p.m. ET. Interested parties may access a ... of the BioMarin website, http://www.BMRN.com . A,replay of ...
... Medical Inc.,(NYSE: SMA ), an independent provider ... other medical markets, announced today that it has,completed ... and Ultra Containers of America (UCA), a leading ... About Symmetry Medical Inc. Symmetry Medical Inc. ...
... Boston, MA It has been known that countries ... that results from undernutrition and overnutrition. People living in ... resources, while affluent individuals may suffer from diseases that ... the Harvard School of Public Health (HSPH) and the ...
... researchers static image of beating heart could be new screening ... to build up in the hearts of pre-diabetic people before ... new study. , Researchers at the University of Texas Southwestern ... technique that could become a new screening tool for people ...
Cached Medicine News:Health News:AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply 2Health News:Nicotine in Breast Milk Shortens Baby's Naptime 2Health News:Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments 2Health News:Income inequality associated with overnourishment and undernourishment in India 2Health News:Fat Builds Up in Hearts Before Diabetes Onset 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: